Using the DUTCH Test while you are on hormone therapy

Why hormone levels are an imperfect guide

The Menopause Society states that optimal hormone levels for postmenopausal women have not been established, that levels vary from day to day, and that how symptoms respond to a dose is the only reliable guide for adjusting hormone therapy. It also advises against saliva testing for this purpose.

That does not make testing useless. It means any test, blood or urine, needs to be read alongside how you feel, your bleeding pattern if you have a uterus, and your safety labs.

How each route shows up in urine

• Transdermal estradiol (patch, gel, cream): enters the bloodstream directly, so urine estrogen results more closely reflect what reaches your body
• Oral estradiol: passes through the liver first, so a larger share is converted to estrone and its metabolites
• Oral progesterone: heavily processed by the liver, producing large amounts of urine metabolites that can make progesterone exposure look higher than blood levels would suggest
• Vaginal estrogen or progesterone: local products can contaminate urine samples, so results may not reflect true absorption
• Testosterone (men or women): urine metabolites show broad patterns, but blood tests remain the standard for monitoring

When a DUTCH Test can help on HRT

Your clinician may suggest it in specific situations: symptoms persist despite a dose that should be adequate, there are signs you are absorbing much more or less than expected from a transdermal product, or you and your clinician want to understand how your body is processing estrogen while on therapy. The cortisol curve can also add context to sleep and energy complaints that persist on HRT.

Timing matters. Your clinician will tell you how to schedule collection relative to your doses, and you should write down when and how you applied or took each product.

When it is not the right test

Some questions need blood work or an exam instead. Men on testosterone need blood testosterone, hematocrit and PSA, which the Endocrine Society uses to define safety limits for therapy. Women with new or unexpected bleeding on HRT need an evaluation of the uterus, not a hormone test.

A urine test also cannot tell you whether hormone therapy is safe for you. That decision rests on an individualized discussion of risks such as blood clots, stroke and breast cancer, and, if you have a uterus, progesterone to protect the endometrium.

A note on recent label changes

In November 2025 the FDA announced it would remove broad boxed warnings about cardiovascular disease, breast cancer and probable dementia from menopausal hormone therapy labels, and the updated labels were approved in February 2026. The boxed warning about endometrial cancer remains for systemic estrogen-alone products used by women with a uterus. These changes do not alter the need for an individualized risk discussion or for progesterone when you have a uterus.

Signs to report whatever your results show

Some symptoms matter more than any number on a report. Contact your clinician about breast tenderness that does not settle, headaches, mood changes or fluid retention after a dose change, and about persistent hot flashes or poor sleep despite treatment. Seek urgent care for leg pain or swelling, chest pain, sudden shortness of breath, sudden severe headache, vision changes or weakness on one side of the body, which can signal a clot or stroke.

For women with a uterus, any bleeding after menopause that was not expected on your regimen should be evaluated, even if hormone results look normal. Men on testosterone should report headaches, flushing or breathing problems at night, which can relate to a high hematocrit or sleep apnea.

Getting the most from testing

• Collect on a typical day at your usual dose, not right after a dose change
• Avoid applying vaginal products before or during collection unless your clinician says otherwise
• Record the exact time of each dose and each sample
• Mention supplements such as DHEA, pregnenolone or herbal products
• Bring a symptom diary so results can be compared with how you feel

How HealifyMD approaches it

Your clinician decides whether a DUTCH Test would actually change your plan before ordering it. If so, you collect at home with a prepaid return to a CLIA-certified laboratory, and your clinician reviews the report with your history and blood work in an online visit. The DUTCH Test costs $449 one-time with no membership fee, confirmed at the eligibility review. It is a laboratory developed test that has not been reviewed by the FDA. Hormone therapy plans are priced separately.